Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR51V1 Inhibitors

The human olfactory receptor, OR51V1, is part of a vast and highly diverse gene family responsible for the detection of volatile odorant molecules. Each olfactory receptor (OR) operates as a specialized sensor within the olfactory epithelium, the sensory organ tasked with odor recognition and transduction of olfactory signals. The intricate process by which these receptors contribute to the sense of smell is a subject of ongoing research and fascination. OR51V1, like other ORs, is encoded by a specific gene that dictates the receptor's structure and function. The expression of this gene, and consequently the abundance of the OR51V1 protein, can be influenced by various internal and external factors. Understanding the regulation of OR51V1 expression is crucial as it provides insights into the mechanisms that govern olfactory perception. Regulatory pathways can be complex, with multiple layers of control that include transcriptional, post-transcriptional, translational, and post-translational modifications, each capable of fine-tuning the expression of olfactory receptors. A number of chemical compounds have been identified that could potentially inhibit the expression of OR51V1. These inhibitors might operate through different modes of action to exert their influence on the receptor's expression. For instance, certain compounds may interfere with the gene transcription machinery directly, altering the rate at which the OR51V1 gene is transcribed into messenger RNA (mRNA). Others might act indirectly by modifying the cellular environment or signaling pathways that influence transcription factor activity. Some inhibitors could affect the stability of OR51V1 mRNA, leading to a reduced half-life and lower levels of translation into the protein product. Additionally, there are chemicals that might inhibit the post-translational processing or transport of the receptor, thereby impacting the availability of OR51V1 at the cell surface where it performs its sensory function. It is also possible for certain compounds to affect OR51V1 expression through epigenetic modifications, which alter the accessibility of the gene to the transcriptional machinery without changing the DNA sequence itself. These modifications can include DNA methylation and histone acetylation, which can either promote or repress gene expression. The study of these inhibitors provides a window into the complex regulatory networks that control gene expression and offers a blueprint for understanding the molecular underpinnings of olfactory function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Methimazole

60-56-0sc-205747
sc-205747A
10 g
25 g
$69.00
$110.00
4
(0)

This antithyroid agent may lead to decreased transcriptional activity of OR51V1 by altering the equilibrium of thyroid hormones that can act on gene expression processes specific to olfactory receptor neurons.

Flutamide

13311-84-7sc-204757
sc-204757A
sc-204757D
sc-204757B
sc-204757C
1 g
5 g
25 g
500 g
1 kg
$46.00
$153.00
$168.00
$515.00
$923.00
4
(1)

As an antiandrogen, Flutamide could downregulate the expression of OR51V1 if its expression is androgen-dependent, by blocking androgen receptors and reducing the receptor-mediated signaling that promotes gene transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

This chemical acts as a DNA methyltransferase inhibitor, potentially leading to the demethylation of the OR51V1 gene promoter region, which could result in the silencing of gene expression if methylation is required for OR51V1 activity.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

Through its action as a histone deacetylase inhibitor, Trichostatin A can cause an increase in acetylated histones, potentially leading to a tightly packed chromatin state around the OR51V1 gene, thereby reducing its transcription.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Chloroquine′s ability to disrupt lysosomal function could lead to the accumulation of misfolded OR51V1 proteins within the cell, triggering cellular mechanisms that target the mRNA for degradation and thus decrease protein levels.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

By inhibiting the transport of proteins from the endoplasmic reticulum to the Golgi apparatus, Brefeldin A could prevent the proper processing and trafficking of OR51V1, leading to its degradation within the cell and reduced expression at the cell surface.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

This compound halts protein synthesis by interfering with the translocation step in protein elongation, which would result in a direct decrease in OR51V1 protein production, effectively reducing its expression post-transcriptionally.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

This antibiotic binds to DNA and prevents the elongation phase of RNA synthesis by RNA polymerase, which would lead to a decrease in OR51V1 mRNA synthesis and subsequent protein expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

By specifically inhibiting the mTOR signaling pathway, Rapamycin can lead to a downregulation of cap-dependent translation, potentially decreasing the synthesis of proteins such as OR51V1.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

This compound is a selective inhibitor of MEK, which could result in the downregulation of OR51V1 by inhibiting the phosphorylation of downstream targets involved in the transcriptional activation of olfactory receptor genes.